Cabaletta Bio Stock Technical Analysis
| CABA Stock | USD 3.06 -0.13 -4.08% |
On the 15th of March 2026, Cabaletta Bio is quoted at 3.06 per share. Observed technical values include risk adjusted performance of 0.0747, and Mean Deviation of 3.97. The framework analyzes price history and volume dynamics to measure short- and intermediate-term momentum. Indicator readings are benchmarked against comparable companies.
Cabaletta Bio Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cabaletta, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CabalettaCabaletta | Build AI portfolio with Cabaletta Stock |
Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 13.13 | Strong Buy | 12 | Odds |
Cabaletta Bio current and past analyst recommendations are summarized from multiple research sources. It also summarizes the average analyst consensus. Wall Street analysts covering Cabaletta Bio typically update their price targets and ratings quarterly following earnings releases. These consensus estimates reflect the collective view of professional researchers who monitor Cabaletta's financials, competitive positioning, and management.
The market value of Cabaletta Bio is measured differently than book value, which reflects Cabaletta accounting equity. Cabaletta Bio's market capitalization is 294.57 M. A P/B ratio of 2.11 indicates the market values Cabaletta Bio above its accounting book value. Enterprise value stands at 160.42 M. Intrinsic value reflects what Cabaletta Bio's fundamentals imply about worth, which may differ from both the trading price and the book figure. Analytical frameworks help reconcile those views.
Note that Cabaletta Bio's intrinsic value and market price are different measures derived from different inputs. For Cabaletta Bio, key inputs include a P/B ratio of 2.11, and ROE of -101.06%. The quoted price is simply the exchange level where supply meets demand.
What if' Analysis
Running a what-if backtest on Cabaletta Bio gives investors a practical way to test how changes in horizon, position size, or market timing might have affected the result. Used properly, this review helps investors decide whether Cabaletta Bio's historical reward profile was stable enough to support the current thesis.
| 12/15/2025 |
| 03/15/2026 |
If you invested 0.00 in Cabaletta Bio on December 15, 2025 and closed the position today, you would earn 0.00 in net gains. This reflects a 0.0% return on investment in Cabaletta Bio in total across 90 days. Cabaletta Bio is related to or competes with Editas Medicine, Allogene Therapeutics, Capricor Therapeutics, Kyverna Therapeutics, Lyell Immunopharma, Atea Pharmaceuticals, and ProQR Therapeutics. This provides context for relative positioning. Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T ce... More
Cabaletta Bio Upside and Downside Indicators Snapshot
Upside and downside indicators for Cabaletta Bio summarize momentum balance and potential range context for the stock. They provide a structured view of short-term momentum and range behavior.
| Downside Deviation | 4.29 | |||
| Information Ratio | 0.0894 | |||
| Maximum Drawdown | 32.97 | |||
| Value At Risk | -7.27 | |||
| Potential Upside | 8.16 |
Cabaletta Bio Market Risk Indicators Snapshot
Market risk indicators summarize volatility and return dispersion for Cabaletta Bio. The signals are informational and describe volatility patterns.| Risk Adjusted Performance | 0.0747 | |||
| Jensen Alpha | 0.5037 | |||
| Total Risk Alpha | 0.7709 | |||
| Sortino Ratio | 0.1165 | |||
| Treynor Ratio | 0.4225 |
Mean reversion is the tendency of Cabaletta Bio's price to return to its historical average after periods of extreme deviation. Investors who identify when Cabaletta Bio's is significantly above or below its mean may find compelling entry or exit opportunities.
Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0747 | |||
| Market Risk Adjusted Performance | 0.4325 | |||
| Mean Deviation | 3.97 | |||
| Semi Deviation | 3.78 | |||
| Downside Deviation | 4.29 | |||
| Coefficient Of Variation | 1202.6 | |||
| Standard Deviation | 5.6 | |||
| Variance | 31.32 | |||
| Information Ratio | 0.0894 | |||
| Jensen Alpha | 0.5037 | |||
| Total Risk Alpha | 0.7709 | |||
| Sortino Ratio | 0.1165 | |||
| Treynor Ratio | 0.4225 | |||
| Maximum Drawdown | 32.97 | |||
| Value At Risk | -7.27 | |||
| Potential Upside | 8.16 | |||
| Downside Variance | 18.44 | |||
| Semi Variance | 14.29 | |||
| Expected Short fall | -5.31 | |||
| Skewness | 1.55 | |||
| Kurtosis | 5.28 |
Cabaletta Bio Backtested Returns
Cabaletta Bio reflects a very high risk exposure within the chosen horizon. It maintains a Sharpe Ratio of 0.0964, illustrating dispersion-adjusted performance. We identified twenty-nine technical indicators influencing the company's volatility profile. Please evaluate metrics such as risk-adjusted performance of 0.0747, and mean deviation of 3.97 to verify consistency between risk and return assumptions. On a scale of 0 to 100, Cabaletta Bio holds a performance score of 7. The firm maintains a market beta of 1.08, which signifies a somewhat significant risk relative to the market. Cabaletta Bio tracks the broader market closely, rising and falling roughly in step with the benchmark. Please verify Cabaletta Bio's the relationship between the downside deviation and total risk alpha, to make a quick decision on whether Cabaletta Bio's current trending patterns will revert.
Auto-correlation | 0.17 |
Very weak predictability
Comparing Cabaletta Bio's price behavior from 15th of December 2025 to 29th of January 2026 with the period from 29th of January 2026 to 15th of March 2026 produces very weak predictability. The stronger the relationship between the current interval and its lagged values, the more accurately future price behavior of Cabaletta Bio may be projected. The coefficient of 0.17 links over 17.0% of Cabaletta Bio's present price action to its own historical movements.
| Correlation Coefficient | 0.17 | |
| Spearman Rank Test | -0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.12 |
Cabaletta Bio technical stock analysis uses price and volume transformations to study behavior. Common inputs include moving averages, RSI, regressions, and price-return correlations.
Technical Analysis
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Cabaletta Bio volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Technical Analysis Methodology & Indicators
Technical analysis of Cabaletta Bio evaluates price structure, momentum, and volatility clustering. Momentum divergence can indicate regime transitions. Cabaletta Bio has a market cap of 294.57 M, ROE of -101.06%.
Data shown for Cabaletta Bio is aggregated from periodic company reporting and market reference feeds and normalized across reporting formats. Analyst inputs may be included when coverage is available. Source publication cadence can introduce delays.
This content is curated and reviewed by:
Vlad Skutelnik - Macroaxis ContributorCabaletta Bio Technical Indicators
A technical review of Cabaletta Bio can improve timing discipline by comparing momentum, reversal risk, and confirmation signals across several time horizons. The stronger process confirms one signal with others instead of reacting to one pattern in isolation.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0747 | |||
| Market Risk Adjusted Performance | 0.4325 | |||
| Mean Deviation | 3.97 | |||
| Semi Deviation | 3.78 | |||
| Downside Deviation | 4.29 | |||
| Coefficient Of Variation | 1202.6 | |||
| Standard Deviation | 5.6 | |||
| Variance | 31.32 | |||
| Information Ratio | 0.0894 | |||
| Jensen Alpha | 0.5037 | |||
| Total Risk Alpha | 0.7709 | |||
| Sortino Ratio | 0.1165 | |||
| Treynor Ratio | 0.4225 | |||
| Maximum Drawdown | 32.97 | |||
| Value At Risk | -7.27 | |||
| Potential Upside | 8.16 | |||
| Downside Variance | 18.44 | |||
| Semi Variance | 14.29 | |||
| Expected Short fall | -5.31 | |||
| Skewness | 1.55 | |||
| Kurtosis | 5.28 |
March 15, 2026 Daily Trend Indicators
A technical review of Cabaletta Bio can improve timing discipline by comparing momentum, reversal risk, and confirmation signals across several time horizons. The stronger process confirms one signal with others instead of reacting to one pattern in isolation.
| Accumulation Distribution | 0.08 | ||
| Daily Balance Of Power | -0.48 | ||
| Rate Of Daily Change | 0.96 | ||
| Day Median Price | 3.14 | ||
| Day Typical Price | 3.12 | ||
| Price Action Indicator | -0.15 | ||
| Market Facilitation Index | 0.27 |
Popular Tools for Cabaletta Stock analysis
| Portfolio Holdings Check your current holdings and cash position to determine if your portfolio needs rebalancing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |